Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tissue Plasminogen Activator”

311 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 311 results

Not applicableStudy completedNCT03578107
What this trial is testing

Improve Acute Reperfusion Treatment Quality for Stroke in China, IMPROVE: Stroke Care in China

Who this might be right for
Ischemic Stroke
Beijing Tiantan Hospital 15,895
Not applicableUnknownNCT04674293
What this trial is testing

Russian Prospective Multicenter Registry Study of Intravenous Thrombolytic Therapy for Acute Ischemic Stroke

Who this might be right for
The Aim the Study is to Collect and Analyze Data on Patients With Acute Ischemic Stroke During Intravenous Thrombolytic Therapy With Alteplase
Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health 500
Testing effectiveness (Phase 2)Study completedNCT03340493
What this trial is testing

Determining the Optimal Dose of Tenecteplase Before Endovascular Therapy for Ischaemic Stroke (EXTEND-IA TNK Part 2)

Who this might be right for
Ischemic Stroke
Neuroscience Trials Australia 300
Not applicableStudy completedNCT02358772
What this trial is testing

Comparison of Pre-hospital and In-hospital Iv-tPA Stroke Treatment

Who this might be right for
Ischemic Stroke
Charite University, Berlin, Germany 658
Early research (Phase 1)Study completedNCT01006993
What this trial is testing

Feasibility and Safety of NeuroFlo in Stroke Patients Receiving Tissue Plasminogen Activator

Who this might be right for
Ischemic Stroke
CoAxia 22
Early research (Phase 1)Study completedNCT00283088
What this trial is testing

Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic Stroke

Who this might be right for
Stroke
University of California, San Diego 130
Testing effectiveness (Phase 2)Ended earlyNCT00252239
What this trial is testing

Study of Tenecteplase (TNK) in Acute Ischemic Stroke (TNK-S2B)

Who this might be right for
Stroke
University of Virginia 112
Large-scale testing (Phase 3)Looking for participantsNCT06660719
What this trial is testing

Efficacy and Safety of SP-8203 (Otaplimastat) in Patients With Acute Ischemic Stroke Receiving Thrombolytic Standard of Care

Who this might be right for
Ischemic Stroke
Shin Poong Pharmaceutical Co. Ltd. 852
Post-approval studies (Phase 4)Enrolling By InvitationNCT07643493
What this trial is testing

CleaRRAflow: Isotonic Solution vs. TPA for IVH Clearance

Who this might be right for
Tissue Plasminogen ActivatorIntraventricular Brain Hemorrhage
David Dornbos 80
Large-scale testing (Phase 3)Study completedNCT00887328
What this trial is testing

Extending the Time for Thrombolysis in Emergency Neurological Deficits

Who this might be right for
Stroke
Neuroscience Trials Australia 180
Not applicableLooking for participantsNCT06621121
What this trial is testing

A Real-world Study of Tenecteplase Versus Alteplase for Thrombolysis in Patients Within 4.5 H of Onset of Ischemic Stroke

Who this might be right for
Stroke AcuteTenecteplaseAlteplase
Tianjin Huanhu Hospital 6,000
Early research (Phase 1)Study completedNCT00055159
What this trial is testing

Low-Dose rtPA to Treat Blood Clots in Major Arm or Neck Veins

Who this might be right for
Thrombosis
National Institutes of Health Clinical Center (CC) 50
Not applicableStudy completedNCT04915586
What this trial is testing

Short Duration High Intensity Intrapleural Alteplase With Pulmozyme in Pleural Infection Management

Who this might be right for
Loculated Empyema
National University of Malaysia 30
Post-approval studies (Phase 4)Study completedNCT04752631
What this trial is testing

MRI-guided thrOmbolysis for Stroke bEyond Time Window by TNK

Who this might be right for
Stroke
General Hospital of Shenyang Military Region 80
Not applicableLooking for participantsNCT07432373
What this trial is testing

Intrapleural Alteplase-Tyloxapol vs Intrapleural Alteplase-DNase in Pleural Infection

Who this might be right for
Pleural Infection
National University of Malaysia 80
Testing effectiveness (Phase 2)Ended earlyNCT01009931
What this trial is testing

Phase II Study of TPA Plus Dexamethasone & CMT in Hematologic Malignancies

Who this might be right for
Leukemia
Rutgers, The State University of New Jersey 1
Post-approval studies (Phase 4)Not Yet RecruitingNCT05910125
What this trial is testing

Aspirin Combined With Clopidogrel Versus Intravenous Alteplase for Acute Minor Stroke

Who this might be right for
Ischemic Stroke
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 472
Testing effectiveness (Phase 2)UnknownNCT02258204
What this trial is testing

Ketamine for Thrombolysis in Acute Ischemic Stroke

Who this might be right for
Stroke
University Hospital, Caen 50
Large-scale testing (Phase 3)Study completedNCT00840671
What this trial is testing

Combined Treatment With Alteplase (Rt-PA) and Cerebrolysin® in Acute Ischemic Hemispheric Stroke

Who this might be right for
Stroke
Ever Neuro Pharma GmbH 119
Testing effectiveness (Phase 2)Study completedNCT04356833
What this trial is testing

Nebulised Rt-PA for ARDS Due to COVID-19

Who this might be right for
COVID
University College, London 35
Next Page